{"id":"anti-spasmodic-agents","safety":{"commonSideEffects":[{"rate":null,"effect":"Dry mouth"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Blurred vision"}]},"_chembl":{"chemblId":"CHEMBL2108941","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These drugs work through multiple mechanisms including anticholinergic activity, direct smooth muscle relaxation, or calcium channel modulation to decrease involuntary muscle contractions. They are commonly used to relieve symptoms of gastrointestinal disorders characterized by abnormal muscle contractions, such as irritable bowel syndrome and functional bowel disorders.","oneSentence":"Antispasmodic agents reduce muscle contractions and spasms by inhibiting smooth muscle contraction in the gastrointestinal tract and other organs.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:42:28.922Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Irritable bowel syndrome"},{"name":"Functional gastrointestinal disorders with spasms"},{"name":"Abdominal pain and cramping"}]},"trialDetails":[{"nctId":"NCT01404923","phase":"PHASE4","title":"Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)","status":"COMPLETED","sponsor":"Laboratoires Mayoly Spindler","startDate":"2009-12","conditions":"Irritable Bowel Syndrome","enrollment":436},{"nctId":"NCT01297556","phase":"NA","title":"Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.","status":"UNKNOWN","sponsor":"Michigan Gastroenterology Institute","startDate":"2011-04","conditions":"Irritable Bowel Syndrome","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"anti spasmodic agents","genericName":"anti spasmodic agents","companyName":"Laboratoires Mayoly Spindler","companyId":"laboratoires-mayoly-spindler","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antispasmodic agents reduce muscle contractions and spasms by inhibiting smooth muscle contraction in the gastrointestinal tract and other organs. Used for Irritable bowel syndrome, Functional gastrointestinal disorders with spasms, Abdominal pain and cramping.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}